Skip to main content

Advertisement

Log in

Endocrine manifestations of craniopharyngioma

  • Special Annual Issue
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Rationale

Due to the proximity of craniopharyngiomas to the hypothalamus and pituitary gland, most children and adolescents presenting with these tumors will exhibit significant endocrine dysfunction. After treatment, these impairments can become a major cause of morbidity and mortality.

Methods

The postoperative course of children undergoing surgery for craniopharyngioma is reviewed.

Conclusion

Even if hormone levels seem to be adequate in the short term after treatment, deficiencies may develop over years and need to be monitored closely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chakrabarty A, Mitchell P, Bridges LR (1998) Craniopharyngioma invading the nasal and paranasal spaces, and presenting as nasal obstruction. Br J Neurosurg 12(4):361–363

    Article  PubMed  Google Scholar 

  2. Sklar CA (1994) Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18–20

    PubMed  Google Scholar 

  3. Robinson AG, Verbalis JG (2003) Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Elsevier Science, Philadelphia, PA, pp 281–329

    Google Scholar 

  4. Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781–785

    PubMed  Google Scholar 

  5. de Vries L, Lazar L, Phillip M (2003) Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16(5):110–703

    PubMed  Google Scholar 

  6. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 97(5):728–735

    PubMed  Google Scholar 

  7. Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587–592

    PubMed  Google Scholar 

  8. Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, Opmeer F, Van den Brande JL (1988) Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr 147(6):658–661

    Article  PubMed  Google Scholar 

  9. Blethen SL, Weldon VV (1986) Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 292(1):21–24

    PubMed  Google Scholar 

  10. Weinzimer SA, Homan SA, Ferry RJ, Moshang T (1999) Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol (Oxf) 51(3):339–345

    Article  Google Scholar 

  11. Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128(5 Pt 2):S4–S7

    PubMed  Google Scholar 

  12. Wilton P, Price DA (1992) Rate of relapse of craniopharyngioma in children treated with growth hormone. KIGS Biannu Rep No 8 1:48–54

    Google Scholar 

  13. Niu DM, Guo WY, Pan HC, Wong TT (2002) Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 18(3–4):164–165. Epub 2002 Mar 5

    Article  PubMed  Google Scholar 

  14. Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10:116–129

    PubMed  Google Scholar 

  15. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88(2):611–616

    Article  PubMed  Google Scholar 

  16. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89(7):3298–3305

    Article  PubMed  Google Scholar 

  17. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S (1998) The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83(5):1467–1471

    Article  PubMed  Google Scholar 

  18. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80(2):374–378

    Article  PubMed  Google Scholar 

  19. Pajas M, Lucas T, Garcia-Uria J, Salame F, Barcelo B, Estrada J (1995) Hypothalamic–pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol (Oxf) 42(5):467–473

    Google Scholar 

  20. Clopper RR, Mazur T, MacGillivray MH, Peterson RE, Voorhess ML (1983) Data on virilization and erotosexual behavior in male hypogonadotropic hypopituitarism during gonadotropin and androgen treatment. J Androl 4(5):303–311

    PubMed  Google Scholar 

  21. Abbaticchio G, Micale FM, Giagulli VA, Giorgino R (1985) Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment. Arch Androl 15(1):59–64

    PubMed  Google Scholar 

  22. Volz J, Heinrich U, Volz-Koster S (2002) Conception and spontaneous delivery after total hypophysectomy. Fertil Steril 77(3):624–625

    Article  PubMed  Google Scholar 

  23. Hayashi M, Tomobe K, Hoshimoto K, Ohkura T (2002) Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. Int J Clin Pract 56(2):149–151

    PubMed  Google Scholar 

  24. Zachmann M, Illig R (1979) Precocious puberty after surgery for craniopharyngioma. J Pediatr 95(1):86–88

    PubMed  Google Scholar 

  25. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85(10):3631–3635

    Article  PubMed  Google Scholar 

  26. Gruneiro-Papendieck L, Chiesa A, Martinez A, Heinrich JJ, Bergada C (1998) Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 50(5):252–257

    Article  PubMed  Google Scholar 

  27. Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A (2001) Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 14(7):869–874

    PubMed  Google Scholar 

  28. Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J, Myllyla VV (2001) Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 42(7):930–934

    Article  PubMed  Google Scholar 

  29. Surks MI, DeFesi CR (1996) Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 275(19):1495–1498

    Article  PubMed  Google Scholar 

  30. Lyen KR, Grant DB (1982) Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57(11):837–841

    PubMed  Google Scholar 

  31. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer, Feb 7

  32. Styne DM, Richards GE, Bell JJ et al (1977) Growth patterns in congenital adrenal hyperplasia: correlation of glucocorticoid therapy with stature. In: Lee P, Plotnick L, Kowarski A, Migeon C (eds) Congenital adrenal hyperplasia. University Park Press, Baltimore, pp 247–261

    Google Scholar 

  33. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F (1990) Cortisol production rate in childhood and adolescence. J Pediatr 117(6):892–896

    PubMed  Google Scholar 

  34. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76(6):1505–1510

    Article  PubMed  Google Scholar 

  35. Miller WL (2003) The adrenal cortex. In: Sperling MA (ed) Pediatric endocrinology. Elsevier Science, Philadelphia, PA pp 385–438

    Google Scholar 

  36. Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279

    Article  PubMed  Google Scholar 

  37. Gonzales-Portillo G, Tomita T (1998) The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases. Neurosurgery 42(4):917–921; discussion 921–922

    Article  PubMed  Google Scholar 

  38. Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189–195

    PubMed  Google Scholar 

  39. Jeanrenaud B (1985) An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28(8):502–513 Review

    Article  PubMed  Google Scholar 

  40. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719–809

    PubMed  Google Scholar 

  41. Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1(8337):1330–1331

    Article  PubMed  Google Scholar 

  42. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162–168

    PubMed  Google Scholar 

  43. Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156(9):887–892

    PubMed  Google Scholar 

  44. Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11–15

    Article  Google Scholar 

  45. Sorva R, Heiskanen O, Perheentupa J (1988) Craniopharyngioma surgery in children: endocrine and visual outcome. Childs Nerv Syst 4(2):97–99

    PubMed  Google Scholar 

  46. Nakasu Y, Nakasu S, Handa J, Takeuchi J (1980) Amenorrhea–galactorrhea syndrome with craniopharyngioma. Surg Neurol 13(2):154–156

    PubMed  Google Scholar 

  47. Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87(8):3993–3996

    Article  PubMed  Google Scholar 

  48. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet 357(9254):425–431

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald Zimmerman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halac, I., Zimmerman, D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 21, 640–648 (2005). https://doi.org/10.1007/s00381-005-1246-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-005-1246-x

Keywords

Navigation